Please provide your email address to receive an email when new articles are posted on . Nearly 80% of patients with cirrhosis awaiting liver transplant reported clinically significant pain. Pain, ...
Around 13% of patients with a dementia diagnosis may instead have advanced liver disease — also called cirrhosis — which can cause reversible cognitive decline, researchers at the Virginia ...
Patients who survive colorectal cancer face a sustained and increased risk of death from chronic liver disease and cirrhosis ...
Sportschosun on MSN
Fatty liver patients with metabolic abnormalities, high cirrhosis, are at risk of complications up t...
In patients with metabolic abnormal fatty liver disease (MASLD), if the blood test index is low but the cirrhosis is high, ...
Please provide your email address to receive an email when new articles are posted on . The pharmacokinetics of survodutide were not affected by cirrhosis. The dual agonist was “generally tolerable” ...
A comprehensive review assessed the ways that proper nutrition could help reduce the adverse effects of hepatic encephalopathy in patients with hepatic encephalopathy. A recent review published in the ...
Rezdiffra FDA approval fuels sales; expansion to F4 MASH cirrhosis with 2027 trial data. Read more about MDGL stock here.
Patients in the Phase 3 MAESTRO-NAFLD-1 trial achieved a statistically significant mean reduction of 6.7 kPa in liver stiffness, the largest reported in compensated MASH cirrhosis populations. 51% of ...
Ramat Gan, Israel, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback